Cargando…
The Humoral Immune Response of the ChAdOx1 nCoV-19 Vaccine in Maintenance Dialysis Patients without Prior COVID-19 Infection
Background: Chronic kidney disease (CKD) patients tend to have a reduced immune response to infection and vaccination. The efficacy of current available COVID-19 vaccines in CKD patients has not been widely evaluated. Methods: In the present study, three hundred and eight chronic dialysis patients r...
Autores principales: | Cheng, Chung-Yi, Fang, Te-Chao, Liao, Hung-Wei, Chen, Tso-Hsiao, Chang, Jer-Hwa, Lin, Yen-Chung, Kao, Chih-Chin, Liu, Ming-Che, Chang, Hui-Wen, Hung, Ching-Sheng, Wang, Jude Chu-Chun, Hsiao, Shih-Hsin, Sue, Yuh-Mou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879203/ https://www.ncbi.nlm.nih.gov/pubmed/35214797 http://dx.doi.org/10.3390/vaccines10020338 |
Ejemplares similares
-
SARS-CoV2 antibody response after a third dose of heterologous ChAdOx1 nCoV-19 and Moderna vaccine in chronic dialysis patients
por: Cheng, Chung-Yi, et al.
Publicado: (2022) -
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
por: Chang, Jer-Hwa, et al.
Publicado: (2022) -
Comparison of Humoral Antibody Responses and Seroconversion Rates between Two Homologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination in Patients Undergoing Maintenance Hemodialysis
por: Hsiao, Shih-Hsin, et al.
Publicado: (2023) -
Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination
por: Sheng, Wang-Huei, et al.
Publicado: (2022) -
Postvaccinal Encephalitis after ChAdOx1 nCov‐19
por: Zuhorn, Frédéric, et al.
Publicado: (2021)